STOCK TITAN

Asensus Surgical, Inc. - $ASXC STOCK NEWS

Welcome to our dedicated page for Asensus Surgical news (Ticker: $ASXC), a resource for investors and traders seeking the latest updates and insights on Asensus Surgical stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Asensus Surgical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Asensus Surgical's position in the market.

Rhea-AI Summary
Asensus Surgical, Inc. announced its operating and financial results for the second quarter of 2023. Key highlights include a 27% YoY growth in surgical procedures, revenue of $1.1 million, and cash and cash equivalents of $40.0 million as of June 30, 2023. The company also completed a $10 million registered direct offering in July 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.7%
Tags
-
Rhea-AI Summary
Asensus Surgical, Inc. has announced a registered direct offering of 23,809,524 shares of common stock and warrants to purchase the same amount of shares at a combined purchase price of $0.42 per share. The offering is expected to close soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.18%
Tags
Rhea-AI Summary
Asensus Surgical, Inc. (NYSE American: ASXC) announced that a leading United States-based hospital has initiated a Senhance Surgical System program for use within their pediatric surgery department. This marks the first system to be exclusively utilized by pediatric surgeons at a United States-based hospital, showcasing Senhance’s unique applicability for pediatric applications. The system, empowered by the Intelligent Surgical Unit™ (ISU™), represents a breakthrough in digital surgical platforms, leveraging augmented intelligence and machine learning for superior surgical performance and patient outcomes. The specialized 3mm instruments are perfectly suited for the delicate nature of pediatric procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.17%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.41%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.85%
Tags
conferences
Asensus Surgical, Inc.

NYSE:ASXC

ASXC Rankings

ASXC Stock Data

66.33M
266.72M
1.97%
9.32%
6.53%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
DURHAM

About ASXC

asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.